Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
272
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+223K
-
Total reported value, excl. options
-
$3.59B
-
Value change
-
+$9.28M
-
Put/Call ratio
-
0.93
-
Number of buys
-
140
-
Number of sells
-
-129
-
Price
-
$100.85
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q3 2023
326 filings reported holding CNMD - CONMED Corp - Common Stock as of Q3 2023.
CONMED Corp - Common Stock (CNMD) has 272 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
.
Largest 10 shareholders include BlackRock Inc. (4.95M shares), VANGUARD GROUP INC (3.44M shares), Capital Research Global Investors (2.47M shares), EARNEST PARTNERS LLC (2.27M shares), STATE STREET CORP (1.18M shares), BANK OF AMERICA CORP /DE/ (1.06M shares), AMERIPRISE FINANCIAL INC (967K shares), Champlain Investment Partners, LLC (943K shares), LOOMIS SAYLES & CO L P (789K shares), and MACQUARIE GROUP LTD (744K shares).
This table shows the top 272 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.